FDA’s Fabricant to deliver keynote address at CRN conference this fall
WASHINGTON — The Council for Responsible Nutrition on Wednesday announced that Daniel Fabricant, director of the Division of Dietary Supplement Programs at the Food and Drug Administration, will deliver the keynote address at The Conference: CRN’s Annual Symposium for the Dietary Supplement Industry on Oct. 20 in Rancho Palos Verdes, Calif.
Fabricant, who recently joined the FDA following stints at the Natural Products Association and ConsumerLab.com, will address the agency’s priorities for the dietary supplement industry, including the FDA’s perspective on the newly released and controversial draft guidance for New Dietary Ingredients.
At the agency, Fabricant is responsible for the full implementation of DSHEA through the interpretation and enforcement of dietary supplement requirements that ensure the safety and truthful labeling of dietary supplements support legislative compliance, enforcement and public affairs initiatives.
“The dietary supplement and nutrition products industries are facing new and serious challenges, as evidenced by publication of [the] FDA’s draft NDI guidance and the recent introduction of S. 1310 by Senator Richard Durbin,” stated John Venardos, chairman of the conference and SVP worldwide regulatory, government and industry affairs for Herbalife. “We are appreciative that Dr. Fabricant will engage with our participants at this industry-wide conference, and his insights will set the stage for a lively, provocative and informative meeting.”
Online registration is available through CRN’s website.
Perrigo closes acquisition of Paddock Labs
ALLEGAN, Mich. — Generic drug maker Perrigo has closed its purchase of Paddock Labs, the company said Tuesday.
Perrigo acquired privately owned Paddock, a manufacturer of generic prescription and over-the-counter drugs based in Minneapolis, for $540 million.
“We are very pleased to welcome the Paddock team to the Perrigo family,” Perrigo chairman and CEO Joseph Papa said. “This acquisition is another important step forward in executing Perrigo’s strategy to expand our specialty portfolio of generic Rx products.”
As part of the purchase, the Federal Trade Commission is requiring Perrigo to divest a small handful of Paddock’s drugs, which it will sell to Watson Pharmaceuticals. The drugs include promethazine hydrochloride suppositories, ciclopirox shampoo and two ammonium lactate medications.
Roeya Badri Vaughan joins Dr. Sears Family Essentials as VP marketing
IRVINE, Calif. — Dr. Sears Family Essentials has appointed a new VP marketing.
Roeya Badri Vaughan will be responsible for driving awareness and sales of the company’s doctor-formulated, kid-approved line of 100% all-natural snacks, beverages and supplements.
Prior to joining Dr. Sears Family Essentials, Vaughan served as head of product marketing at Arbonne, where she spearheaded the relaunch of its flagship anti-aging skin care line, introduced a comprehensive cosmetics line and developed a breakthrough line of nutrition products.
"With her experience and impressive achievements building brands, I am confident Roeya will help bring the Dr. Sears Family Essentials product line to a wider audience, ultimately benefiting families nationwide," Dr. Sears Family Essentials CEO Tom Hicks said.